The German chemicals giant withdraws after two rejected takeover proposals, ending months of speculation over a potential combination that could have reshaped the global animal nutrition and dairy feed ingredients markets.
November 20, 2026 | Germany
BASF SE has officially abandoned its pursuit of Evonik Industries AG, bringing an end to a potential acquisition that had attracted considerable attention across the global chemical, animal nutrition and feed industries.
Announced on November 19, 2026, the decision follows Evonik’s rejection of two non-binding all-cash takeover proposals submitted by BASF. The German chemical manufacturer said it had assessed the potential transaction and concluded that there were insufficient grounds to justify increasing its offer further.
BASF also indicated that although it had been prepared to consider a moderate increase in its proposal, Evonik’s Executive Board had not demonstrated meaningful engagement with the acquisition discussions.
The withdrawal marks the conclusion of a takeover pursuit that began attracting attention on September 25, when BASF confirmed exploratory discussions involving Evonik and its largest shareholder, the RAG Foundation.
A €11.2 Billion Proposal Fails to Secure Agreement
BASF’s pursuit involved two proposals, with its latest offer reportedly valuing Evonik at approximately €11.2 billion, equivalent to €24 per share.
Despite the financial proposal and BASF’s willingness to consider further adjustments, Evonik remained unconvinced about the potential combination.
BASF Chairman and CEO Dr Markus Kamieth maintained that the company’s €24-per-share all-cash proposal represented significant additional value for Evonik shareholders. He also argued that bringing the two businesses together could create a stronger chemical company with additional value for shareholders, employees and customers.
However, BASF ultimately concluded that Evonik’s standalone business prospects and associated risks did not justify paying a higher acquisition premium.
The decision also reflects BASF’s commitment to its capital allocation strategy, under which acquisitions are considered an opportunity rather than a necessity for strengthening its core businesses.
What the Failed Acquisition Means for Animal Nutrition and Dairy
Although the proposed acquisition primarily concerned the broader chemical industry, its potential implications extended into animal nutrition, an important business area for both companies.
Both BASF and Evonik have established positions in the global feed ingredients market, supplying nutritional solutions that support livestock productivity, feed efficiency and animal health.
BASF’s Animal Nutrition portfolio includes vitamins, carotenoids, enzymes, organic acids and other specialised feed additives. These ingredients contribute to improved nutrient utilisation, animal performance and resource efficiency across livestock production systems.
Its solutions also have direct applications in dairy farming. For example, BASF supplies propylene glycol, an energy-rich feed ingredient used particularly in dairy cattle during early lactation to address energy deficiencies associated with the transition period.
Evonik, meanwhile, has a strong presence in amino acid-based animal nutrition, particularly methionine and specialised nutritional solutions. Its portfolio also includes products developed specifically for dairy cattle.
At EuroTier 2026, held in Hanover from November 10–13, Evonik presented its MetAMINO methionine solutions alongside new specialised nutrition products. These included Lypron, a rumen-protected lysine solution designed to support amino acid balancing, dairy cow performance and improved nitrogen efficiency.
The possibility of combining the companies therefore raised questions about potential synergies in research, manufacturing, distribution and customer-facing nutritional solutions.
However, the termination of the takeover means both businesses will continue developing their animal nutrition strategies independently.
EuroTier 2026 Highlights the Industry’s Strategic Priorities
The takeover speculation coincided with EuroTier 2026, where animal nutrition innovation, feed efficiency and sustainable livestock production remained important industry themes.
Expana had approached the animal nutrition divisions of both companies during the exhibition to understand whether a possible takeover would influence their existing plans and what strategic advantages could emerge from bringing their respective businesses closer together.
With BASF now withdrawing its acquisition proposals, the possibility of an integrated animal nutrition business under common ownership has effectively disappeared for the time being.
Nevertheless, the companies’ existing product portfolios demonstrate how specialised feed ingredients are becoming increasingly important to modern dairy production.
For dairy farmers and feed manufacturers, solutions supporting rumen function, amino acid efficiency, metabolic health and improved feed conversion remain essential to managing production costs while maintaining milk yield and animal wellbeing.
Independent Strategies Will Shape the Next Phase
The end of BASF’s takeover pursuit removes uncertainty surrounding Evonik’s ownership prospects and allows both companies to concentrate on their respective business priorities.
For BASF, the decision reinforces its focus on financial discipline, shareholder value and investments that deliver attractive returns.
For Evonik, remaining independent provides an opportunity to continue developing its animal nutrition portfolio, including specialised amino acid solutions and precision nutrition technologies.
For the global dairy industry, the immediate impact is not a change in feed ingredient availability or product portfolios, but the continuation of two separate suppliers pursuing their own innovation and commercial strategies.
The proposed acquisition may have ended, but competition in animal nutrition remains firmly focused on improving feed efficiency, supporting livestock health and making dairy production more sustainable.